Zetia Buyers Defend Class Cert. As 'Common Business Sense'

By Bryan Koenig (February 9, 2022, 5:33 PM EST) -- Direct buyers of cholesterol drug Zetia urged a Virginia federal court Tuesday to reject a recommendation against class certification in multidistrict litigation accusing Merck and Glenmark of scheming to delay generic versions, arguing that presumptions of dozens of wholesalers joining without certification ignores business realities....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!